Cargando…

Integrated inflammatory signaling landscape response after delivering Elovanoid free-fatty-acid precursors leading to experimental stroke neuroprotection

Despite efforts to identify modulatory neuroprotective mechanisms of damaging ischemic stroke cascade signaling, a void remains on an effective potential therapeutic. The present study defines neuroprotection by very long-chain polyunsaturated fatty acid (VLC-PUFA) Elovanoid (ELV) precursors C-32:6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reid, Madigan M., Belayev, Ludmila, Khoutorova, Larissa, Mukherjee, Pranab K., Obenaus, Andre, Shelvin, Kierany, Knowles, Stacey, Hong, Sung-Ha, Bazan, Nicolas G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516907/ https://www.ncbi.nlm.nih.gov/pubmed/37740008 http://dx.doi.org/10.1038/s41598-023-42126-w

Ejemplares similares

Synergistic Neuroprotection by a PAF Antagonist Plus a Docosanoid in Experimental Ischemic Stroke: Dose-Response and Therapeutic Window
por: Reid, Madigan M., et al.
Publicado: (2022)

Elovanoids are a novel class of homeostatic lipid mediators that protect neural cell integrity upon injury
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2017)

Combined Therapy With Avastin, a PAF Receptor Antagonist and a Lipid Mediator Inhibited Glioblastoma Tumor Growth
por: Cruz Flores, Valerie A., et al.
Publicado: (2021)

Neuroprotectin D1 upregulates Iduna expression and provides protection in cellular uncompensated oxidative stress and in experimental ischemic stroke
por: Belayev, Ludmila, et al.
Publicado: (2017)

Elovanoids are novel cell-specific lipid mediators necessary for neuroprotective signaling for photoreceptor cell integrity
por: Jun, Bokkyoo, et al.
Publicado: (2017)

Superior Neuroprotective Efficacy of LAU-0901, a Novel Platelet-Activating Factor Antagonist, in Experimental Stroke
por: Belayev, Ludmila, et al.
Publicado: (2011)

Docosahexaenoic acid complexed to human albumin in experimental stroke: neuroprotective efficacy with a wide therapeutic window
por: Eady, Tiffany N, et al.
Publicado: (2012)

Blocking pro-inflammatory platelet-activating factor receptors and activating cell survival pathways: A novel therapeutic strategy in experimental ischemic stroke
por: Belayev, Ludmila, et al.
Publicado: (2020)

DHA modulates MANF and TREM2 abundance, enhances neurogenesis, reduces infarct size, and improves neurological function after experimental ischemic stroke
por: Belayev, Ludmila, et al.
Publicado: (2020)

NPD1 Plus RvD1 Mediated Ischemic Stroke Penumbra Protection Increases Expression of Pro-homeostatic Microglial and Astrocyte Genes
por: Reid, Madigan M., et al.
Publicado: (2023)

Docosahexaenoic acid improves behavior and attenuates blood–brain barrier injury induced by focal cerebral ischemia in rats
por: Hong, Sung-Ha, et al.
Publicado: (2015)

Acute Treatment with Docosahexaenoic Acid Complexed to Albumin Reduces Injury after a Permanent Focal Cerebral Ischemia in Rats
por: Eady, Tiffany N., et al.
Publicado: (2013)

Docosahexaenoic Acid Therapy of Experimental Ischemic Stroke
por: Belayev, Ludmila, et al.
Publicado: (2010)

Elovanoids are neural resiliency epigenomic regulators targeting histone modifications, DNA methylation, tau phosphorylation, telomere integrity, senescence programming, and dendrite integrity
por: Bazan, Nicolas, et al.
Publicado: (2023)

cRel and Wnt5a/Frizzled 5 Receptor-Mediated Inflammatory Regulation Reveal Novel Neuroprotectin D1 Targets for Neuroprotection
por: Calandria, Jorgelina M., et al.
Publicado: (2022)

Docosahexaenoic Acid Signaling Modulates Cell Survival in Experimental Ischemic Stroke Penumbra and Initiates Long-Term Repair in Young and Aged Rats
por: Eady, Tiffany N., et al.
Publicado: (2012)

Correction to: cRel and Wnt5a/Frizzled 5 Receptor-Mediated Inflammatory Regulation Reveal Novel Neuroprotectin D1 Targets for Neuroprotection
por: Calandria, Jorgelina M., et al.
Publicado: (2022)

Elovanoids downregulate SARS-CoV-2 cell-entry, canonical mediators and enhance protective signaling in human alveolar cells
por: Calandria, Jorgelina M., et al.
Publicado: (2021)

Elovanoids counteract oligomeric β-amyloid-induced gene expression and protect photoreceptors
por: Do, Khanh V., et al.
Publicado: (2019)

Overview of how N32 and N34 elovanoids sustain sight by protecting retinal pigment epithelial cells and photoreceptors
por: Bazan, Nicolas G.
Publicado: (2021)

Elovanoid-N32 or RvD6-isomer decrease ACE2 and binding of S protein RBD after injury or INFγ in the eye
por: Pham, Thang L., et al.
Publicado: (2020)

Multiprong control of glioblastoma multiforme invasiveness: blockade of pro-inflammatory signaling, anti-angiogenesis, and homeostasis restoration
por: Bazan, Nicolas G., et al.
Publicado: (2021)

Elovanoids Counteract Inflammatory Signaling, Autophagy, Endoplasmic Reticulum Stress, and Senescence Gene Programming in Human Nasal Epithelial Cells Exposed to Allergens
por: Resano, Alfredo, et al.
Publicado: (2022)

Proinsulin: From Hormonal Precursor to Neuroprotective Factor
por: de la Rosa, Enrique J., et al.
Publicado: (2011)

Neuroprotective effect of hyperbaric oxygen therapy in a juvenile rat model of repetitive mild traumatic brain injury
por: Huang, Lei, et al.
Publicado: (2016)

The Neuroprotective Properties of the Amyloid Precursor Protein Following Traumatic Brain Injury
por: Plummer, Stephanie, et al.
Publicado: (2016)

Neuroprotective Effects of Thiamine and Precursors with Higher Bioavailability: Focus on Benfotiamine and Dibenzoylthiamine
por: Sambon, Margaux, et al.
Publicado: (2021)

NPD1-mediated stereoselective regulation of BIRC3 expression through cREL is decisive for neural cell survival
por: Calandria, J M, et al.
Publicado: (2015)

Intracellular sorting pathways of the amyloid precursor protein provide novel neuroprotective strategies
por: Hermey, Guido
Publicado: (2015)

Corrigendum: Dysfunctional epileptic neuronal circuits and dysmorphic dendritic spines are mitigated by platelet-activating factor receptor antagonism
por: Musto, Alberto E., et al.
Publicado: (2016)

Dysfunctional epileptic neuronal circuits and dysmorphic dendritic spines are mitigated by platelet-activating factor receptor antagonism
por: Musto, Alberto E., et al.
Publicado: (2016)

The Shifting Public Health Landscape and Virtual Learning Environment: The Effectiveness of Practice-Based Teaching Delivered In-Person, Virtual, and Hybrid
por: Cunnington, Stacey, et al.
Publicado: (2023)

Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
por: Ryland, Georgina L., et al.
Publicado: (2015)

Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions
por: Wu, Ren‐Chin, et al.
Publicado: (2019)

Protophones, the precursors to speech, dominate the human infant vocal landscape
por: Oller, D. Kimbrough, et al.
Publicado: (2021)

Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain
por: Antoniou, Xanthi, et al.
Publicado: (2010)

Multi-Level Evolution for Robotic Design
por: Chand, Shelvin, et al.
Publicado: (2021)

Injectable, photoresponsive hydrogels for delivering neuroprotective proteins enabled by metal-directed protein assembly
por: Jiang, Bojing, et al.
Publicado: (2020)

Distribution in the brain and possible neuroprotective effects of intranasally delivered multi-walled carbon nanotubes
por: Soligo, Marzia, et al.
Publicado: (2020)

Melatonin delivered in solid lipid nanoparticles ameliorated its neuroprotective effects in cerebral ischemia
por: Sohail, Saba, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4f4mmhjdpb0dhju60f8smtru4u